Why Z-drugs are used even if doctors and nurses feel unable to judge their benefits and risks-a hospital survey.
Stephanie HeinemannJürgen BrockmöllerYork HagmayerWolfgang HimmelPublished in: European journal of clinical pharmacology (2019)
Z-drugs seem to be attractive because experiential knowledge overemphasizes their benefits and fails to take risks such as drug-related falls and confusion into account. Difficulties to judge a drug's risk-benefit ratio do not prevent doctors and nurses from using them. Interventions for reducing Z-drug usage should incorporate local quality assurance data about relevant patient risks.